Publicaciones en las que colabora con José Antonio Páramo Fernández (19)

2021

  1. Association of sdf1 and mmp12 with atherosclerosis and inflammation: Clinical and experimental study

    Life, Vol. 11, Núm. 5

2019

  1. Analysis of monocitary subpopulations in relation to cardiovascular risk factors

    Clinica e Investigacion en Arteriosclerosis, Vol. 31, Núm. 4, pp. 152-159

  2. Análisis de subpoblaciones monocitarias en relación con los factores de riesgo cardiovascular

    Clínica e investigación en arteriosclerosis, Vol. 31, Núm. 4, pp. 152-159

  3. Risk factors and impact of portal vein thrombosis in liver transplantation

    Revista Espanola de Enfermedades Digestivas, Vol. 111, Núm. 6, pp. 437-444

2015

  1. Matrix Metalloproteinase 10 Contributes To Hepatocarcinogenesis in a Novel Crosstalk With the Stromal Derived Factor 1/C-X-C Chemokine Receptor 4 Axis

    Hepatology, Vol. 62, Núm. 1, pp. 166-178

  2. Radioembolization of hepatocellular carcinoma activates liver regeneration, induces inflammation and endothelial stress and activates coagulation

    Liver International, Vol. 35, Núm. 5, pp. 1590-1596

2014

  1. Matrix metalloproteinase-10 expression is induced during hepatic injury and plays a fundamental role in liver tissue repair

    Liver International, Vol. 34, Núm. 7

2012

  1. Synergistic effect of thrombin and CD40 ligand on endothelial matrix metalloproteinase-10 expression and microparticle generation in vitro and in vivo

    Arteriosclerosis, Thrombosis, and Vascular Biology, Vol. 32, Núm. 6, pp. 1477-1487

2008

  1. Asociación de marcadores inflamatorios y aterosclerosis subclínica en relación con la edad en sujetos sin enfermedad cardiovascular

    Medicina Clinica, Vol. 131, Núm. 10, pp. 361-365

  2. Common variable immunodeficiency and Evans syndrome complicated by autoimmune hemolysis due to anti-Jka auto-antibodies

    Leukemia and Lymphoma

2007

  1. Metaloproteasa-10 (estromelisina-2): un nuevo marcador de aterosclerosis subclínica

    Clínica e investigación en arteriosclerosis, Vol. 19, Núm. 3, pp. 122-128

2005

  1. Independent association of von Willebrand factor with surrogate markers of atherosclerosis in middle-aged asymptomatic subjects

    Journal of Thrombosis and Haemostasis, Vol. 3, Núm. 4, pp. 662-664

  2. Monocyte cyclooxygenase-2 overactivity: A new marker of subclinical atherosclerosis in asymptomatic subjects with cardiovascular risk factors?

    European Heart Journal, Vol. 26, Núm. 2, pp. 153-158

2004

  1. Prothrombin fragment 1+2 is associated with carotid intima-media thickness in subjects free of clinical cardiovascular disease

    Stroke, Vol. 35, Núm. 5, pp. 1085-1089

2003

  1. Independent association of fibrinogen with carotid intima-media thickness in asymptomatic subjects

    Cerebrovascular Diseases, Vol. 16, Núm. 4, pp. 356-362

1997

  1. Prevalence of hypercoagulation conditions in patients with thrombosis in Northern Navarra

    Anales de medicina interna (Madrid, Spain : 1984), Vol. 14, Núm. 9, pp. 450-454

1995

  1. Increased concentrations of tumor necrosis factor and lnterleukin-6 contribute to the hemostatic abnormalities in advanced liver disease

    Pathophysiology of Haemostasis and Thrombosis, Vol. 25, Núm. 6, pp. 305-311

  2. REDUCCION DE LOS REQUERIMIENTOS DE HEMODERIVADOS EN EL TRASPLANTE HEPATICO CON APROTININA

    Revista Espanola de Anestesiologia y Reanimacion, Vol. 42, Núm. 3, pp. 82-86

1993

  1. Effectiveness of aprotinin in orthotopic liver transplantation

    Seminars in Thrombosis and Hemostasis